Literature DB >> 7891974

Persistent endophthalmitis after intravitreal antimicrobial therapy.

A Shaarawy1, M G Grand, T A Meredith, H E Ibanez.   

Abstract

PURPOSE: To assess the frequency of persistent infection after injection of intravitreal antimicrobials as therapy for endophthalmitis and to determine if persistent infection influences the final visual outcome after treatment.
METHODS: In a series of 42 eyes with culture-positive endophthalmitis of various types, the authors performed a second vitreous culture and injection of antimicrobial agents in 22 eyes. Repeat cultures were obtained 3 to 8 days after initial therapy in 20 of the 22 eyes.
RESULTS: Twelve of the 22 eyes were persistently culture-positive. Organisms identified in the persistently culture-positive eyes included staphylococcal species (n = 4), Streptococcus (n = 4), Serratia (n = 1), Propionibacterium acnes (n = 1), and fungi (n = 2). Eyes in which the initial antimicrobial therapy failed to eradicate a bacterial infection had a worse outcome than those that were culture-negative on repeat sampling. Final visual acuity of 20/200 or better after repeat injection was attained in 4 of the 12 culture-positive eyes.
CONCLUSION: A single injection of intravitreal antimicrobial agents may be insufficient to cure some cases of endophthalmitis, and a second injection should be considered in some circumstances.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7891974     DOI: 10.1016/s0161-6420(95)31011-1

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  13 in total

Review 1.  Current approach to postoperative endophthalmitis.

Authors:  G Sunaric-Mégevand; C J Pournaras
Journal:  Br J Ophthalmol       Date:  1997-11       Impact factor: 4.638

2.  Persistently Vitreous Culture-Positive Exogenous Bacterial Endophthalmitis.

Authors:  Ella H Leung; Ajay E Kuriyan; Harry W Flynn; Darlene Miller; Laura C Huang
Journal:  Am J Ophthalmol       Date:  2016-02-26       Impact factor: 5.258

3.  An outbreak of streptococcus endophthalmitis after intravitreal injection of bevacizumab.

Authors:  Roger A Goldberg; Harry W Flynn; Ryan F Isom; Darlene Miller; Serafin Gonzalez
Journal:  Am J Ophthalmol       Date:  2012-02       Impact factor: 5.258

Review 4.  Endophthalmitis following open-globe injuries.

Authors:  Y Ahmed; A M Schimel; A Pathengay; M H Colyer; H W Flynn
Journal:  Eye (Lond)       Date:  2011-12-02       Impact factor: 3.775

5.  Enterobacter cloacae endophthalmitis: report of four cases.

Authors:  N Okhravi; L Ficker; M M Matheson; S Lightman
Journal:  J Clin Microbiol       Date:  1998-01       Impact factor: 5.948

6.  Streptococcus endophthalmitis outbreak after intravitreal injection of bevacizumab: one-year outcomes and investigative results.

Authors:  Roger A Goldberg; Harry W Flynn; Darlene Miller; Serafin Gonzalez; Ryan F Isom
Journal:  Ophthalmology       Date:  2013-02-28       Impact factor: 12.079

7.  Endophthalmitis caused by Enterococcus faecalis: clinical features, antibiotic sensitivities, and outcomes.

Authors:  Ajay E Kuriyan; Jayanth Sridhar; Harry W Flynn; William E Smiddy; Thomas A Albini; Audina M Berrocal; Richard K Forster; Peter J Belin; Darlene Miller
Journal:  Am J Ophthalmol       Date:  2014-08-01       Impact factor: 5.258

8.  Acute postoperative endophthalmitis caused by Staphylococcus lugdunensis.

Authors:  C Chiquet; A Pechinot; C Creuzot-Garcher; Y Benito; J Croize; S Boisset; J P Romanet; G Lina; F Vandenesch
Journal:  J Clin Microbiol       Date:  2007-03-28       Impact factor: 5.948

9.  Intravenous treatment of experimental Staphylococcus aureus endophthalmitis: imipenem versus the combination of ceftazidime and amikacin.

Authors:  Michael Engelbert; Herminia Miño de Kaspar; Martina Mette; Martin Thiel; Christopher N Ta; Thomas Grasbon; Markus Schulze-Schwering; Volker Klauss; Anselm Kampik
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2003-11-14       Impact factor: 3.117

10.  FRIENDS Group: clinical and microbiological characteristics of post-filtering surgery endophthalmitis.

Authors:  E Brillat-Zaratzian; A Bron; F Aptel; J P Romanet; P L Cornut; F Vandenesch; S Boisset; M Maurin; C Chiquet
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2013-11-19       Impact factor: 3.117

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.